Literature DB >> 6201865

Development of methotrexate resistance in a human squamous cell carcinoma of the head and neck in culture.

E Frei, A Rosowsky, J E Wright, C A Cucchi, J A Lippke, T J Ervin, J Jolivet, W A Haseltine.   

Abstract

Four methotrexate (MTX)-resistant sublines of a human squamous cell carcinoma (SCC15) were established in culture by progressive dose escalation. The biochemical basis of resistance was studied. The line with the lowest resistance (R1) had a normal dihydrofolate reductase (DHFR) content but showed decreased MTX transport and polyglutamation. Lines of intermediate resistance (R2 and R3) showed an increased DHFR content and DHFR gene copy number and a defect in MTX transport. The line with the greatest resistance (R4) showed increased DHFR content and gene copy number but nearly normal MTX transport. These results demonstrate that multiple mechanisms of MTX resistance occur in human epithelial cells in culture. We also find evidence of alterations in DHFR gene expression. The MTX-resistant cells were either not cross-resistant or only partly cross-resistant to two lipophilic MTX ester derivatives. These compounds are of potential therapeutic interest for the treatment of MTX-resistant tumors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201865      PMCID: PMC345174          DOI: 10.1073/pnas.81.9.2873

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Characteristics of transport of 4-amino antifolates and folate compounds by two lines of L5178Y lymphoblasts, one with impaired transport of methotrexate.

Authors:  B T Hill; B D Bailey; J C White; I D Goldman
Journal:  Cancer Res       Date:  1979-07       Impact factor: 12.701

2.  Changes of molecular properties associated with the development of resistance against methotrexate in human lymphoblastoid cells.

Authors:  D Niethammer; R C Jackson
Journal:  Eur J Cancer       Date:  1975-12       Impact factor: 9.162

3.  A rapid, radiochemical-ligand binding assay for methotrexate.

Authors:  B A Kamen; P L Takach; R Vatev; J D Caston
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

4.  Synthesis and degradation of folate reductase in sensitive and methotrexate-resistant lines of S-180 cells.

Authors:  F W Alt; R E Kellems; R T Schimke
Journal:  J Biol Chem       Date:  1976-05-25       Impact factor: 5.157

5.  Acquired methotrexate resistance in lymphoblasts resulting from altered kinetic properties of dihydrofoltate reductase.

Authors:  R C Jackson; D Niethammer
Journal:  Eur J Cancer       Date:  1977-06       Impact factor: 9.162

6.  Methotrexate analogues. 11. Unambiguous chemical synthesis and in vitro biological evaluation of alpha- and gamma-monoesters as potential prodrugs.

Authors:  A Rosowsky; G P Beardsley; W D Ensminger; H Lazarus; C S Yu
Journal:  J Med Chem       Date:  1978-04       Impact factor: 7.446

7.  Quantitation of dihydrofolate reductase in individual parental and methotrexate-resistant murine cells. Use of a fluorescence activated cell sorter.

Authors:  R J Kaufman; J R Bertino; R T Schimke
Journal:  J Biol Chem       Date:  1978-08-25       Impact factor: 5.157

8.  Transport and metabolism of methotrexate in normal and resistant cultured rat hepatoma cells.

Authors:  J Galivan
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

9.  Methotrexate analogs. 2. A facile method of preparation of lipophilic derivatives of methotrexate and 3',5'-dichloromethotrexate by direct esterification.

Authors:  A Rosowsky
Journal:  J Med Chem       Date:  1973-10       Impact factor: 7.446

10.  A human dihydrofolate reductase pseudogene and its relationship to the multiple forms of specific messenger RNA.

Authors:  J N Masters; J K Yang; A Cellini; G Attardi
Journal:  J Mol Biol       Date:  1983-06-15       Impact factor: 5.469

View more
  20 in total

Review 1.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Polyglutamation of methotrexate. Is methotrexate a prodrug?

Authors:  B A Chabner; C J Allegra; G A Curt; N J Clendeninn; J Baram; S Koizumi; J C Drake; J Jolivet
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

3.  DNA amplification is rare in normal human cells.

Authors:  J A Wright; H S Smith; F M Watt; M C Hancock; D L Hudson; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage.

Authors:  T G Paulson; A Almasan; L L Brody; G M Wahl
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

5.  Reduced membrane protein associated with resistance of human squamous carcinoma cells to methotrexate and cis-platinum.

Authors:  S D Bernal; J A Speak; K Boeheim; A I Dreyfuss; J E Wright; B A Teicher; A Rosowsky; S W Tsao; Y C Wong
Journal:  Mol Cell Biochem       Date:  1990-06-01       Impact factor: 3.396

6.  Identification of methotrexate transport deficiency in mammalian cells using fluoresceinated methotrexate and flow cytometry.

Authors:  Y G Assaraf; R T Schimke
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

7.  Development of alkylating agent-resistant human tumor cell lines.

Authors:  B A Teicher; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  Alkylating agent resistance: in vitro studies with human cell lines.

Authors:  E Frei; C A Cucchi; A Rosowsky; R Tantravahi; S Bernal; T J Ervin; R M Ruprecht; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

9.  Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates.

Authors:  K N Chung; Y Saikawa; T H Paik; K H Dixon; T Mulligan; K H Cowan; P C Elwood
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 10.  Biological and biochemical properties of new anticancer folate antagonists.

Authors:  D W Fry; R C Jackson
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.